Washington, DC—The Connected Health Initiative conducted a national poll of Americans asking how they wear, share, and pay for their wearable devices. With the surge in popularity of wearable health [...]
05/01/2023–Comments on the Food and Drug Administration’s Discussion Paper on Artificial Intelligence in Drug Manufacturing [Docket No. FDA-2023-N-0487; 88 FR 12943]
CHI Comments re FDA Discussion Paper AI in Drug Manufacturing (050123)
On March 10, 2023, Representatives Miller-Meeks, Craig, and Murphy introduced legislation requiring the Food and Drug Administration (FDA) to conduct a study and issue recommendations on improving medical device data interoperability.
Brian Scarpelli, executive director of the Connected Health Initiative (CHI), expressed CHI’s support for the bill: “Interoperability is critical to realize the promise of digital health and enable better, more [...]
The Promise of Digital Health Exists, Connected Health Initiative Urges Congress to Achieve Potential January 31, 2023—Today, ACT | The App Association’s Connected Health Initiative (CHI) released its priorities for [...]
With the CMS Physician Fee Schedule issuance, details and takeaways are now available. Notably, consistent with our advocacy over the last few years urging CMS to make remote therapeutic monitoring [...]